CAS announces collaboration with Novartis to advance AI-ready reaction informatics

CAS announces collaboration with Novartis to advance AI-ready reaction informatics

This collaboration between CAS and Novartis establishes a unified framework for integrating proprietary experimental reaction data with extensive curated external databases. By standardizing diverse internal data sources through advanced curation services, the partnership creates a synthetic data foundation that enhances accessibility for computational research, machine learning, and AI applications. This approach transforms fragmented research records into a cohesive, searchable asset, significantly improving the efficiency of reaction data discovery and analysis. The initiative further develops a custom search platform based on established scientific architecture, allowing researchers to simultaneously explore internal and external reaction data. This tool addresses the critical challenge of cross-referencing disparate information sources, thereby supporting more confident decision-making in drug discovery workflows. The resulting infrastructure is designed to facilitate future advancements in large language models and agentic AI, ensuring that scientific data remains a reliable and valuable resource for innovation. This development is highly relevant to open data as it exemplifies the importance of structured, standardized, and interoperable scientific datasets. It highlights how transforming siloed, proprietary information into accessible, machine-readable formats can accelerate global research progress. By demonstrating the successful integration of domain-specific curation with broad technological platforms, this case study underscores the potential for open data principles to enhance AI readiness and foster collaboration within the scientific community.

Source: manilatimes.net
Published on 2026-09-30